1. Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies. (December 2018) Authors: Wu, Yi-Long; Lee, Victor; Liam, Chong-Kin; Lu, Shun; Park, Keunchil; Srimuninnimit, Vichien; Wang, Jie; Zhou, Caicun; Appius, Anita; Button, Peter; Hooper, Gregory; Palma, John F.; Schulze, Katja; Scudder, Sidney; Shames, David S.; Yin, Anny-Yue; Zhang, Guili; Mok, Tony Journal: Lung cancer Issue: Volume 126(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗